Low cost, efficient, intracellular cargo delivery
Researchers from Eric Mazur’s lab at Harvard have developed a new intracellular delivery technique using laser-activated thermoplasmonic substrates that can deliver cargos of varying sizes to cells with high efficiency, viability, and throughput. This technique is cost-effective, reproducible, and has spatial selectivity with no toxic residue.
This new technique is a paradigm shift in intracellular delivery, which can be impactful across different disease areas and therapeutic modalities. It has the potential to advance fields such as nanotechnology, fundamental biology, and medicine, and could pave the way for safer genetic and viral disease therapies.
This work was published in Biomedical Optics Express .
Researchers from Eric Mazur’s lab at Harvard have developed a new intracellular delivery technique using laser-activated thermoplasmonic substrates that can deliver cargos of varying sizes to cells with high efficiency, viability, and throughput. This technique is cost-effective, reproducible, and has spatial selectivity with no toxic residue.
This new technique is a paradigm shift in intracellular delivery, which can be impactful across different disease areas and therapeutic modalities. It has the potential to advance fields such as nanotechnology, fundamental biology, and medicine, and could pave the way for safer genetic and viral disease therapies.
This work was published in Biomedical Optics Express .
U.S. Patent(s) Issued: 10,829,729